Dye-based vs virtual chromoendoscopy for pouch surveillance in FAP
Official title: ENDOPOL: Dye chromoENDOscopy Versus Virtual Chromoendoscopy for Assessment of the Ileo-anal Pouch in Patients With Familial Adenomatous POLyposis: a Randomized Controlled Trial
Run by London North West Healthcare NHS Trust · NCT07726771 · Data updated 2026-11-12
This trial tests whether dye-based chromoendoscopy or virtual chromoendoscopy better detects adenomas during routine pouchoscopy in adults with FAP and an ileal pouch-anal anastomosis.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | London North West Healthcare NHS Trust Academic / other |
| Locations | 1 site (London, London) |
| Status | Recruiting |
| Started | July 9, 2026 |
| Main results expected | July 9, 2031 |
| Study ends | July 9, 2031 |
| Registry record updated | July 24, 2026 |
| Trial ID | NCT07726771 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) with FAP who have an IPAA and are undergoing routine surveillance pouchoscopy at participating centers.
✕Probably not a fit
Patients whose adenoma risk or anatomy limits benefits from advanced imaging approaches may see little difference between techniques.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This international, multicenter randomized trial compares dye-based chromoendoscopy using Indigo Carmine with virtual chromoendoscopy (NBI/BLI) during surveillance pouchoscopy in adults with familial adenomatous polyposis and an ileal pouch-anal anastomosis. Participants are randomized 1:1 to either technique and undergo their usual endoscopic surveillance, with any adenomas treated as per standard practice during the same procedure. The study aims to generate high-quality evidence to inform the preferred chromoendoscopy approach in this setting, where current guidelines are inconclusive. The anticipated duration is about two years, and procedures are performed by endoscopists experienced in FAP).
Why it matters
Potential benefit: If successful, the trial could identify a superior imaging approach that improves adenoma detection during pouch surveillance.
How similar studies have gone: Evidence in other endoscopic settings supports improved visualization with advanced imaging, but this direct comparison in FAP pouch surveillance is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: ALL of the following: 1. Diagnosis of FAP i.e., at least one of following: * Genetic diagnosis: proven APC germline mutation OR * Clinical diagnosis: \>100 colorectal adenomas in combination with a positive family history of FAP 2. Have an ileal-pouch anal anastomosis (IPAA), either after primary proctocolectomy or secondary proctectomy after initial colectomy and ileorectal or ileosigmoidal anastomosis (IRA/ISA) 3. Age ≥ 18 years Exclusion Criteria: ANY of the following 1. Diagnosis of FAP i.e., at least one of following: * Genetic diagnosis: proven APC germline mutation OR * Clinical diagnosis: \>100 colorectal adenomas in combination with a positive family history of FAP 2. Have an ileal-pouch anal anastomosis (IPAA), either after primary proctocolectomy or secondary proctectomy after initial colectomy and ileorectal or ileosigmoidal anastomosis (IRA/ISA) 3. Age ≥ 18 years
Where it's running
-
St Mark's Hospital Polyposis Registry (St Mark's Centre for Familial Intestinal Cancer)
London, London, United Kingdom Recruiting
Study contacts
- Principal investigator: Andre Latchford, MBBS PhD FRCP — London North West University Healthcare Nhs Trust
- Study coordinator: Andrew Latchford, MBBS PhD FRCP
- Email: andrew.latchford@nhs.net
- Phone: +442088643232
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Phase 3 eRapa treatment for people with Familial Adenomatous Polyposis
This will see if taking eRapa instead of placebo can slow disease progression and reduce polyps in adults with Familial Adenomatous Polyposis (FAP).
-
FOG-001 treatment for advanced or metastatic solid tumors
This study is testing a new drug called FOG-001 to see if it can help people with advanced solid tumors, especially those with certain genetic changes, when traditional treatments aren't working.
-
Ultrasound vs CT calcium scoring to reclassify symptomatic chest pain
This study tests whether carotid ultrasound can reclassify risk in adults with chest pain and suspected chronic coronary syndrome, compared with the CT calcium score.
-
3D contrast-enhanced microvascular ultrasound to detect new blood vessel growth in carotid plaques
This test tries to see if 3D contrast-enhanced ultrasound can detect tiny new blood vessels inside carotid artery plaques in adults who previously had carotid CEUS.
-
Comparing Texture and Colour Enhancement Imaging (TXI) with high-definition white-light endoscopy for finding dysplasia during IBD surveillance
This will test whether TXI helps doctors find precancerous dysplasia better than standard high-definition white-light colonoscopy in adults with long-standing inflammatory bowel disease having surveillance colonoscopy.
-
Comparing stress echocardiography and CT coronary angiography for chronic coronary syndrome
This study is testing whether a combination of stress echocardiography and carotid ultrasound works better than regular CT scans for diagnosing heart problems in adults with chronic coronary syndrome.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.